Farmacosmo board confirms 2026 industrial plan targets after reviewing H1 revenue data

Reuters2026/07/30 07:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Farmacosmo’s board reviewed unaudited consolidated management figures for 1H26, confirming the group’s 2026 industrial plan targets.
Recorded 2Q26 group revenue of EUR 9.9 million, up 19% from 1Q26 revenue of EUR 8.4 million.
Reported 1H26 group revenue of EUR 18.4 million, down 10% from EUR 20.4 million a year earlier.
Reiterated focus on higher-margin retail channels, citing growth across group platforms in 2Q26 versus 1Q26.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Farmacosmo S.p.A. published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Farmacosmo board confirms 2026 industrial plan targets after reviewing H1 revenue data

You may also like

Crypto prices